Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus.

about

Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus.

Item

http://www.wikidata.org/entity/Q54245484

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Successful combination of dire ...... h recurrent hepatitis C virus.

@en

Successful combination of dire ...... h recurrent hepatitis C virus.

@nl

type

Item

label

Successful combination of dire ...... h recurrent hepatitis C virus.

@en

Successful combination of dire ...... h recurrent hepatitis C virus.

@nl

prefLabel

Successful combination of dire ...... h recurrent hepatitis C virus.

@en

Successful combination of dire ...... h recurrent hepatitis C virus.

@nl

P1476

Successful combination of dire ...... h recurrent hepatitis C virus.

@en

P2093

Christian Rupp

http://www.w3.org/2001/XMLSchema#string

Daniel Nils Gotthardt

http://www.w3.org/2001/XMLSchema#string

Jan Pfeiffenberger

http://www.w3.org/2001/XMLSchema#string

Karl-Heinz Weiss

http://www.w3.org/2001/XMLSchema#string

Manuel Neuberger

http://www.w3.org/2001/XMLSchema#string

Peter Sauer

http://www.w3.org/2001/XMLSchema#string

Theresa Hippchen

http://www.w3.org/2001/XMLSchema#string

Wolfgang Stremmel

http://www.w3.org/2001/XMLSchema#string

P2860

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection

Management of hepatitis C infection before and after liver transplantation

The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort.

Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease.

The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection.

Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.

Interferon-free antiviral treatment of chronic hepatitis C in the transplant setting.

P304

1353-1360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V24.I12.1353

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Arianeb Mehrabi

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29599610

http://www.w3.org/2001/XMLSchema#string

P932

5871830

http://www.w3.org/2001/XMLSchema#string